Navigation Links
Calibr and JDRF Partner to Support Diabetes Translational Research
Date:3/25/2013

LA JOLLA, Calif., March 25, 2013 /PRNewswire-USNewswire/ -- The California Institute for Biomedical Research (Calibr) and JDRF announced a partnership today to apply Calibr's drug discovery expertise to type 1 diabetes research projects in collaboration with academic investigators from JDRF's network. Termed the Translational Academic Research Partnership, the jointly funded Calibr-JDRF program will establish collaborative projects focused on promising type 1 diabetes therapeutic targets and the discovery of early drug leads for validation and follow-on development.  The initial collaborative projects will be seeded by leading academic investigators working in the area of beta cell biology. Calibr's Matt Tremblay explained the rationale, "The idea is to team up Calibr's chemical and high-throughput screening technologies with the beta cell experts from JDRF's network to validate targets and create new drug discovery programs in areas of novel biology."  The first year of the program will focus on promoting survival of pancreatic beta cells as an approach to restoring blood glucose control in type 1 diabetic patients.

About JDRF

JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF's goal is to progressively remove the impact of T1D from people's lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.

As the largest charitable supporter of T1D research, JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. More than 80 percent of JDRF's expenditures directly support research and research-related education. In 2012 Forbes magazine named JDRF one of its five All-Star charities, citing the organization's efficiency and effectiveness.

For more information, please visit www.jdrf.org.   

About Calibr: The California Institute for Biomedical Research (Calibr) is an independent, not-for-profit organization established to accelerate the translation of basic biomedical research to innovative new medicines. The Institute partners with academic scientists around the world to translate research discoveries and new technologies into innovative new therapies for unmet medical needs. Calibr is led by Peter G. Schultz , Ph.D., a world-renowned chemist, biotechnology entrepreneur and Professor of Chemistry at The Scripps Research Institute in San Diego, CA. Located in San Diego, Calibr is housed in newly built labs located near The Scripps Research Institute, The Salk Institute for Biological Studies, the University of California, San Diego and Sanford-Burnham Medical Research Institute.

Contact:
The California Institute for Biomedical Research (Calibr)
Amit Bhatia
VP of Finance & Operations
T: +1-858-242-1000
F: +1-858-242-1001 
abhatia@calibr.org


'/>"/>
SOURCE The California Institute for Biomedical Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Fluke Calibration 9190A Ultra-Cool Field Metrology Well delivers best-in-class stability
2. Masy Systems Now NVLAP Accredited To Perform RH Calibrations
3. NSG Precision Has Perfected the Wavelength Accuracy Calibration Standard
4. NSG Precision Cells’ WAV-7 Didymium Standard Makes Calibrating Wavelength Accuracy a Snap
5. The WAV-1 UV/VIS Holmium Oxide Calibration Standard by NSG Precision Stands Alone Above the Competition
6. NSG Precision Leads Industry with Solid-State Nano-Deposition Calibration Standards
7. RoviSys Partners with POMS MES to Expand Life Sciences Capabilities
8. TaxOps Announces Partner Appointment to Prominent International Position with Fortune 100 Company
9. NineSigma Announces Winners in $25,000 Sustainable Packaging Challenge in Conjunction With Scientists Without Borders and Partners
10. Accelrys Announces Strategic Partnership with USDM
11. MedCity News and UBM Medica US Partner in Distribution of Health IT News
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... , ... May 23, 2017 , ... Vortex Biosciences ... “Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology ” in ... of a collaboration with Dr. Dino Di Carlo and Dr. Matthew Rettig at the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Customers ... their control technology again and again. METTLER TOLEDO has released two new videos ... videos illustrate how integration of the ACT350 into Siemens and Allen Bradley PLCs ...
(Date:5/21/2017)... ... 20, 2017 , ... CNSDose is a genetically driven, clinically ... by finding the right antidepressant faster. CNSDose speeds recovery and reduces side ... personalized approach to treatment. , A peer-reviewed and published, 12-week double-blind ...
(Date:5/18/2017)... ... , ... Clinical Supplies Management (“CSM”), a Great Point Partners II (“GPP”) portfolio ... CSM has doubled in size over the past six months with the acquisition of ... Gasper joins CSM as Chief Financial Officer. Roger has over 25 years of ...
Breaking Biology Technology:
(Date:5/6/2017)... SINGAPORE , May 5, 2017 ... has just announced a new breakthrough in biometric ... that exploits quantum mechanical properties to perform ... new smart semiconductor material created by Ram Group ... across finance, entertainment, transportation, supply chains and security. ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/17/2017)... April 17, 2017 NXT-ID, Inc. (NASDAQ: ... the filing of its 2016 Annual Report on Form 10-K on ... ... is available in the Investor Relations section of the Company,s website ... SEC,s website at http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):